Clinical trial
An Open Label 24-Week, Flexible Dose Trial to Assess the Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies
NCT00230997 is registered in ClinicalTrials.gov with Neurological Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label 24-Week, Flexible Dose Trial to Assess the Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies
- Lead sponsor
- Neurological Research Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2002
- Completion date
- August 31, 2004
- Enrollment
- 50
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.